Free Trial
→ The AI stocks about to become worthless (and one that isn't) (From InvestorPlace) (Ad)tc pixel Free GSK Stock Alerts

GSK (GSK) News Today

GSK logo
$50.48 -0.05 (-0.09%)
Closing price 05/7/2026 03:59 PM Eastern
Extended Trading
$50.60 +0.12 (+0.24%)
As of 05/7/2026 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

GSK Latest News

129,513 Shares in GSK PLC Sponsored ADR $GSK Acquired by PFA Pension Forsikringsaktieselskab
May 5 at 5:53 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-129513-shares-in-gsk-plc-sponsored-adr-gsk-acquired-by-pfa-pension-forsikringsaktieselskab-2026-05-05/
A Look At GSK (LSE:GSK) Valuation After Recent Share Price Weakness And Pipeline Developments
May 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/look-gsk-lse-gsk-valuation-210624898.html
GSK (GSK) Completes $950M Acquisition to Expand Drug Pipeline
May 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/gsk-gsk-completes-950m-acquisition-075214045.html
GSK Juggles Alzheimer’s Setback And Leadership Shift With Product Progress
May 2, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/gsk-juggles-alzheimer-setback-leadership-011900077.html
Illustration showing a glowing green upward arrow alongside DNA strands, a pill capsule, and molecular structures outside a modern office building.
The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat (GSK)
Big Pharma stalwarts AbbVie, AstraZeneca, and GSK beat Q1 revenue expectations, raising guidance and offering a potential tailwind for the flailing medical sector.
May 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/stock-ideas/the-most-important-part-of-these-3-big-pharma-earnings-reports-wasnt-the-beat/
Illustration showing a glowing green upward arrow alongside DNA strands, a pill capsule, and molecular structures outside a modern office building.
The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat (GSK)
Big Pharma stalwarts AbbVie, AstraZeneca, and GSK beat Q1 revenue expectations, raising guidance and offering a potential tailwind for the flailing medical sector.
May 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/stock-ideas/the-most-important-part-of-these-3-big-pharma-earnings-reports-wasnt-the-beat/
GSK PLC Sponsored ADR Announces Quarterly Dividend of $0.44 (NYSE:GSK)
May 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/gsk-plc-sponsored-adr-announces-quarterly-dividend-of-044-nysegsk-2026-05-01/
JP Morgan retains 'underweight' on GSK with £17 price target as earnings upgrade potential seen as limited
April 30, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1091510/jp-morgan-retains-underweight-on-gsk-with-17-price-target-as-earnings-upgrade-potential-seen-as-limited-1091510.html
Why GSK (GSK) is a Top Value Stock for the Long-Term
April 30, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/why-gsk-gsk-top-value-134002479.html
GSK Canada secures priority review for regulatory submission of bepirovirsen, a potential functional cure treatment for chronic hepatitis B
April 30, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/gsk-canada-secures-priority-review-110000655.html
GSK PLC (GSK) Q1 2026 Earnings Call Highlights: Strong Sales Growth and Strategic Pipeline Expansion
April 30, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/gsk-plc-gsk-q1-2026-070511008.html
GSK plc (GSK) Q1 2026 Earnings Call Transcript
April 29, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4895728-gsk-plc-gsk-q1-2026-earnings-call-transcript
Is GSK (LSE:GSK) Pricing Its Strong Multi Year Share Gains Fairly Today
April 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/gsk-lse-gsk-pricing-strong-140725897.html
GSK Q1 Earnings Beat Estimates, Specialty Medicines Drive Sales Growth
April 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/gsk-q1-earnings-beat-estimates-142900743.html
GSK (NYSE:GSK) Shares Gap Down - Should You Sell?
April 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/gsk-nysegsk-shares-gap-down-should-you-sell-2026-04-29/
GSK (GSK) Tops Q1 Earnings and Revenue Estimates
April 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/gsk-gsk-tops-q1-earnings-111002487.html
GSK Q1 Earnings Call Highlights
April 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/gsk-q1-earnings-call-highlights-2026-04-29/
GSK plc 2026 Q1 - Results - Earnings Call Presentation
April 29, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4895688-gsk-plc-2026-q1-results-earnings-call-presentation
GSK (NYSE:GSK) Updates FY 2026 Earnings Guidance
April 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/gsk-nysegsk-updates-fy-2026-earnings-guidance-2026-04-29/
UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
April 29, 2026  |  cnbc.comhttps://www.cnbc.com/2026/04/29/astrazeneca-gsk-q1-earnings-stock-sales-profit-trump-mfn-pharma.html
GSK Earnings Boosted by Higher Specialty Medicine Sales
April 29, 2026  |  wsj.comhttps://www.wsj.com/business/earnings/gsk-earnings-boosted-by-higher-specialty-medicine-sales-64d5ee9f
GSK beats quarterly profit estimates on strength in respiratory, general medicines
April 29, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/gsk-beats-quarterly-profit-estimates-strength-respiratory-general-medicines-2026-04-29/
Traders Purchase Large Volume of GSK Call Options (NYSE:GSK)
April 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/traders-purchase-large-volume-of-gsk-call-options-nysegsk-2026-04-28/
GSK unit wins partial dismissal in dostarlimab licence dispute with AnaptysBio
April 27, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1091209/gsk-unit-wins-partial-dismissal-in-dostarlimab-licence-dispute-with-anaptysbio-1091209.html
GSK PLC Sponsored ADR (NYSE:GSK) Given Average Recommendation of "Reduce" by Brokerages
April 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/gsk-plc-sponsored-adr-nysegsk-given-average-recommendation-of-reduce-by-brokerages-2026-04-27/
4DMedical GSK Lung Imaging Deal And What It May Mean For Investors
April 24, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/4dmedical-gsk-lung-imaging-deal-020640891.html
GSK (GSK) Earnings Expected to Grow: Should You Buy?
April 22, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/gsk-gsk-earnings-expected-grow-140019676.html
GSK (GSK) Expected to Announce Quarterly Earnings on Wednesday
April 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/gsk-gsk-expected-to-announce-quarterly-earnings-on-wednesday-2026-04-22/
Farther Finance Advisors LLC Grows Stock Position in GSK PLC Sponsored ADR $GSK
April 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-farther-finance-advisors-llc-grows-stock-position-in-gsk-plc-sponsored-adr-gsk-2026-04-21/
GSK wins China approval for Blenrep for refractory multiple myeloma
April 20, 2026  |  lse.co.ukhttps://www.lse.co.uk/news/gsk-wins-china-approval-for-blenrep-for-refractory-multiple-myeloma-a9ykdgrvbl931wi.html
GSK PLC Sponsored ADR $GSK Shares Sold by Miller Howard Investments Inc. NY
April 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-gsk-plc-sponsored-adr-gsk-shares-sold-by-miller-howard-investments-inc-ny-2026-04-20/
GSK Respiratory Breakthrough And Pipeline Advances Reshape Long Term Outlook
April 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/gsk-respiratory-breakthrough-pipeline-advances-030635930.html
GSK: 'Strong Buy' On Mo-Rez Oncology Expansion Potential
April 19, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4891854-gsk-strong-buy-on-mo-rez-oncology-expansion-potential
Suddenly investors can’t get enough of GSK shares! What’s going on?
April 18, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/suddenly-investors-t-enough-gsk-090000231.html
GSK PLC Sponsored ADR (NYSE:GSK) Sees Significant Growth in Short Interest
April 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/gsk-plc-sponsored-adr-nysegsk-sees-significant-growth-in-short-interest-2026-04-16/
Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab
April 15, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/adimab-collaborator-gsk-receives-additional-160300576.html
Rockville R&D campus loan in special servicing as GSK prepares to vacate
April 14, 2026  |  bizjournals.comhttps://www.bizjournals.com/washington/news/2026/04/14/gi-partners-gsk-rialto-capital-special-servicing.html
GSK touts early trial results for targeted cancer drug with blockbuster hopes
April 14, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/gsk-touts-early-trial-results-for-targeted-cancer-drug-with-blockbuster-hopes/ar-AA20RJCr
SLE Market Evolution Accelerates as AstraZeneca's Saphnelo SC Emerges as a Likely Key Challenger to GSK's Benlysta
April 14, 2026  |  marketwatch.comhttps://www.marketwatch.com/press-release/sle-market-evolution-accelerates-as-astrazeneca-s-saphnelo-sc-emerges-as-a-likely-key-challenger-to-gsk-s-benlysta-7c596bb6
Cancer drug licensed by GSK from China posts promising trial results
April 13, 2026  |  ft.comhttps://www.ft.com/content/67afa8b1-58e6-4295-9927-ac1b5ddb863e?syn-25a6b1a6=1
SLE Market Evolution Accelerates as AstraZeneca’s Saphnelo SC Emerges as a Likely Key Challenger to GSK’s Benlysta
April 13, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/sle-market-evolution-accelerates-as-astrazeneca-s-saphnelo-sc-emerges-as-a-likely-key-challenger-to-gsk-s-benlysta-1036015989
GSK Plans Five Late-Stage Cancer Trials As Shares Rise Nearly 50%
April 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/gsk-plans-five-stage-cancer-164832357.html
GSK bets big on cancer comeback with aggressive trial push
April 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4574238-gsk-bets-big-on-cancer-comeback-with-aggressive-trial-push
GSK CEO follows oncology rivals’ playbook in search of growth
April 12, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/gsk-ceo-follows-oncology-rivals-playbook-in-search-of-growth/ar-AA20IaIt
GSK reports promising early results in ovarian and womb cancer drug trial
April 12, 2026  |  theguardian.comhttps://www.theguardian.com/business/2026/apr/12/gsk-promising-early-results-ovarian-womb-cancer-drug-trial
GSK follows oncology rivals’ playbook in search of growth
April 12, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/gsk-follows-oncology-rivals-playbook-in-search-of-growth/ar-AA20IaIt
GSK sees blockbuster potential in targeted cancer therapy after promising early data
April 12, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/gsk-sees-blockbuster-potential-targeted-cancer-therapy-after-promising-early-2026-04-12/
GSK PLC Sponsored ADR $GSK Shares Acquired by Prime Capital Investment Advisors LLC
April 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-gsk-plc-sponsored-adr-gsk-shares-acquired-by-prime-capital-investment-advisors-llc-2026-04-12/
Why GSK (GSK) is a Top Momentum Stock for the Long-Term
April 10, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/why-gsk-gsk-top-momentum-135002458.html
Is It Too Late To Reassess GSK (LSE:GSK) After Its Strong Share Price Run?
April 10, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/too-reassess-gsk-lse-gsk-190953799.html
Get GSK News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GSK Media Mentions By Week

GSK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GSK
News Sentiment
▼
0.61

0.49
▲
Average
Medical
News Sentiment

GSK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GSK Articles
This Week
▼
8

8
▲
GSK Articles
Average Week

Get the Latest News and Ratings for GSK and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GSK and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
Headlines Tools

This page (NYSE:GSK) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners
Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever
"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Why I flew on a tiny helicopter next to a potential nuclear bomb target
Satellite Confirms: Elon Musk Activating Strange 'Dark Energy' Across U.S. South Confirmed by satellites 30...
Altimetry | Sponsoredtc pixel
One executive order. The biggest wealth transfer of your lifetime.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel